EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment
2016 ◽
Vol 17
(3)
◽
pp. 320-327
◽
Dan Que
◽
He Xiao
◽
Baojian Zhao
◽
Xu Zhang
◽
Qiushi Wang
◽
...
2015 ◽
Vol 26
◽
pp. vii83
Masayuki Takeda
◽
Isamu Okamoto
◽
Kazuhiko Nakagawa
2012 ◽
Vol 78
(1)
◽
pp. 39-44
◽
Akihiko Kawahara
◽
Tomoki Taira
◽
Koichi Azuma
◽
Masaki Tominaga
◽
Satoshi Hattori
◽
...
2015 ◽
Vol 88
(1)
◽
pp. 74-79
◽
Masayuki Takeda
◽
Isamu Okamoto
◽
Kazuhiko Nakagawa
2020 ◽
Vol 26
(8)
◽
pp. 2037-2046
◽
Kohsuke Isomoto
◽
Koji Haratani
◽
Hidetoshi Hayashi
◽
Shigeki Shimizu
◽
Shuta Tomida
◽
...
Zhehai Wang
◽
Shu Fang
◽
Jun Guo
◽
Jie Liu
◽
Changzheng Li
◽
...
2018 ◽
Vol 6
(20)
◽
pp. 405-405
◽
Lu Xu
◽
Xin-Hua Xu
◽
Cheng Yuan
◽
Jia-Yu Zhang
◽
Xi Tang
◽
...
2017 ◽
Vol 9
(3)
◽
pp. 470-473
Yusuke Okuma
◽
Yukio Hosomi
2018 ◽
Vol 10
(7)
◽
pp. 4169-4177
◽
Shirong Zhang
◽
Lucheng Zhu
◽
Xueqin Chen
◽
Xiaochen Zhang
◽
Enguo Chen
◽
...
K. Kunimasa
◽
N. Katakami
◽
K. Masago
◽
H. Yoshioka
◽
K. Tomii
◽
...